The India Watch

Jubilant Co. is set to sell a $139 million interest in a US corporation

<p><strong>NEW DELHI:</strong> For $139.4 million, Jubilant Pharma, a division of Jubilant Pharmova, will sell its whole 25.8% ownership in Sofie Biosciences, a US company. According to a statement from the firm, Singapore-based Jubilant Pharma contributed $25 million to Sofie in November 2020.</p>
<p><img decoding=”async” class=”alignnone wp-image-382453″ src=”” alt=” jubilant co is set to sell a 139 million interest in a us corporation 107274025 1″ width=”1017″ height=”572″ title=”Jubilant Co. is set to sell a $139 million interest in a US corporation 15″ srcset=” 400w,×220.png 390w,×84.png 150w” sizes=”(max-width: 1017px) 100vw, 1017px” /></p>
<p>Sofie is a company that develops and provides molecular medicines and diagnostics (theranostics). It possesses an advanced contract manufacturing services network, a radiopharmaceutical production and distribution network, and valuable therapeutic intellectual property.<br />
It and several private equity groups have recently finalized their merger deal.</p>

Related posts

Tata Tech, Gandhar Oil, Airtel, UltraTech, Zomato, ZEE, and Other Stocks to Monitor

As CMD of BHEL, Koppu Sadashiv Murthy assumes leadership

Three Techniques for Preventing Land Encroachment and Protecting Your Property

Sensible guidelines for women in leadership

Stop PAN Card Abuse: Follow These Steps To Report Fraud And Verify Status

What Justifies Every Parent From Opening A PPF Account For Their Child?